3rd Quarter - Report

FIRST STRATEGIC for TRANSLATIONAL GENOMICS RESEARCH INSTITUTE

Firm
Client
Income
$20,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

S.2022, Ending the Diagnostic Odyssey Act.

LobbyistCovered position, as disclosed
KURT R DAVIS —

Bills named: S. 2022 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.